SAHPRA (the South African Health Products Regulatory Authority) regulates medicine registration, scheduling, and import controls, so any peptide bought outside the regulated dispensing chain carries personal regulatory risk
However, direct BDNF therapeutics face a fundamental challenge: the protein does not cross the blood-brain barrier
That difference in signal duration explains almost every divergence in the side-effect profiles
Inquire about the supplier's quality control processes, material traceability, and batch testing protocols
While some nootropics offer promising cognitive benefits , the article emphasizes the importance of understanding their mechanisms, potential side effects, and the necessity of choosing high-quality, well-researched products for optimal results